Scarica l'app Stockscreener
3.79
5.49%
-0.22
Dopo l'orario di chiusura:
3.93
0.14
+3.69%
Precedente Chiudi:
$4.01
Aprire:
$3.89
Volume 24 ore:
381.94K
Relative Volume:
0.33
Capitalizzazione di mercato:
$133.90M
Reddito:
$59.63M
Utile/perdita netta:
$-72.21M
Rapporto P/E:
-1.8048
EPS:
-2.1
Flusso di cassa netto:
$-30.85M
1 W Prestazione:
+1.34%
1M Prestazione:
+25.50%
6M Prestazione:
+14.16%
1 anno Prestazione:
-40.13%
Intervallo 1D:
$3.61
$3.95
Intervallo di 1 settimana:
$3.55
$4.20
Portata 52W:
$1.81
$7.4802
908 Devices Inc Stock (MASS) Company Profile
Nome
908 Devices Inc
Settore
Industria
Telefono
978-729-4478
Indirizzo
645 SUMMER STREET, BOSTON
Confronta MASS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MASS
908 Devices Inc
|
3.79 | 133.90M | 59.63M | -72.21M | -30.85M | -2.10 |
|
ABT
Abbott Laboratories
|
124.50 | 215.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
92.64 | 137.02B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.39 | 132.98B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.54 | 105.84B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.26 | 39.98B | 5.72B | 4.17B | 259.90M | 6.97 |
908 Devices Inc Stock (MASS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-13 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-02-07 | Iniziato | Stephens | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-01-12 | Iniziato | Cowen | Outperform |
| 2021-01-12 | Iniziato | SVB Leerink | Outperform |
| 2021-01-12 | Iniziato | Stifel | Buy |
| 2021-01-12 | Iniziato | William Blair | Outperform |
Mostra tutto
908 Devices Inc Borsa (MASS) Ultime notizie
908 Devices Leads These 3 Penny Stocks To Consider - Yahoo Finance
908 Devices (NASDAQ:MASS) Earns Sell (D-) Rating from Weiss Ratings - Defense World
The Zacks Analyst Blog Highlights Fidelity NASDAQ Composite Index ETF, ThredUp, 908 Devices, Logility Supply Chain, Palomar and EZCORP - Nasdaq
Charles Schwab Investment Management Inc. Has $444,000 Stake in 908 Devices Inc. (NASDAQ:MASS) - Defense World
908 Devices (NASDAQ:MASS) Given Sell (E+) Rating at Weiss Ratings - Defense World
Q1 Earnings Estimate for 908 Devices Issued By William Blair - Defense World
908 Devices (MASS) Stock Jumps on Strength of New Order Announcement - Stocks Telegraph
908 Devices gets $1.7M order from Ministry of Health of Ukraine - MSN
908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device - 01net
908 Devices climbs on $1.7 mln order from Ukraine - TradingView
908 Devices secures $1.7 million order from Ukraine - Investing.com India
908 Devices secures $1.7 million order from Ukraine By Investing.com - Investing.com South Africa
908 Devices Receives $1.7M Order From The Ministry Of Health Of Ukraine For Its Handheld Mass Spec Device - Marketscreener.com
What Is The Outlook For 908 Devices Inc (NASDAQ: MASS) Like For Short-Term? - Stocks Register
908 Devices: Strategic Divestiture and Strong Financial Performance Drive Buy Rating - TipRanks
Repligen Corporation’s Acquisition of Bioprocessing PAT Device Portfolio from 908 Devices - Global Legal Chronicle
Weiss Ratings Reaffirms Sell (E+) Rating for 908 Devices (NASDAQ:MASS) - Defense World
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates - MSN
908 Devices Inc. SEC 10-K Report - TradingView
Repligen buying 908 Devices’ Bioprocess Analytics portfolio - BioWorld Online
908 Devices Makes Key Divestiture (Rating Upgrade) (NASDAQ:MASS) - Seeking Alpha
908 Devices earnings missed by $0.33, revenue fell short of estimates - Investing.com Australia
Stifel maintains Buy on 908 Devices, target steady at $6 By Investing.com - Investing.com Canada
Stifel maintains Buy on 908 Devices, target steady at $6 - Investing.com India
908 Devices Inc. Reports Strategic Transformation and Growth - MSN
Repligen lays down $70m to buy analytics tech from 908 Devices - BioProcess Insider
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices - Genetic Engineering & Biotechnology News
908 Devices Inc.'s (NASDAQ:MASS) 55% Jump Shows Its Popularity With Investors - Simply Wall St
908 Devices Inc (MASS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - Yahoo Finance
908 Devices stock surges on strategic transformation and growth outlook By Investing.com - Investing.com South Africa
908 Devices stock surges on strategic transformation and growth outlook - Investing.com
Repligen Corporation acquired the assets related to bioprocessing analytics portfolio of 908 Devices Inc. for $56 million. - Marketscreener.com
908 Devices jumps as Repligen buys bioprocessing analytics portfolio - MSN
Earnings call transcript: 908 Devices Q4 2024 revenue up 31%, stock surges - Investing.com India
MASS’s 2023 Market Dance: Up 66.78% – Time to Invest? - The InvestChronicle
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth - Benzinga
Strategic Divestment and Focus on Growth Propel 908 Devices to a Buy Rating - TipRanks
908 Devices reports Q4 EPS (56c), consensus (35c) - TipRanks
908 Devices Inc. reports results for the quarter ended December 31Earnings Summary - TradingView
Repligen Corporation acquired Bioprocessing Analytics Portfolio from 908 Devices Inc. for $70 million. - Marketscreener.com
Repligen’s Strategic Acquisition of 908 Devices’ Bioprocessing Assets Boosts Buy Rating - TipRanks
MASSive Gains for 908 Devices: Is This Stock Turning Around? - RagingBull
908 Devices Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
Investor presentation (03/04/2025 00: 00 - Marketscreener.com
Repligen Acquires 908 Devices’ Bioprocess Analytics Portfolio - Contract Pharma
908 DEVICES Earnings Results: $MASS Reports Quarterly Earnings - Nasdaq
908 Devices stock jumps on Repligen deal (RGEN:NASDAQ) - Seeking Alpha
908 Devices Inc Azioni (MASS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.14%
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):